These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12270387)

  • 41. Antibody therapy in steroid-resistant rejection.
    Waiser J; Budde K; Schreiber M; Böhler T; Löbermann LA; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):1778-9. PubMed ID: 9723279
    [No Abstract]   [Full Text] [Related]  

  • 42. Pancreas after kidney transplantation: HLA mismatch does not preclude success.
    Basadonna GP; Auersvald LA; Oliveira SC; Friedman AL; Lorber MI
    Transplant Proc; 1997; 29(1-2):667. PubMed ID: 9123470
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction.
    Burke GW; Ciancio G; Alejandro R; Roth D; Ricordi C; Tzakis A; Miller J
    Transplant Proc; 1998 Jun; 30(4):1544-5. PubMed ID: 9636627
    [No Abstract]   [Full Text] [Related]  

  • 44. Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.
    Kliem V; Petersen R; Ehlerding G; Schaumann D; Eisenberger U; Koch KM; Pichlmayr R; Brunkhorst R
    Transplant Proc; 1998 Jun; 30(4):1251-3. PubMed ID: 9636509
    [No Abstract]   [Full Text] [Related]  

  • 45. Simultaneous pancreas-kidney transplantation: five-year results from a single center.
    Martins L; Pedroso S; Henriques AC; Dias L; Sarmento AM; Seca R; Oliveira F; Dores J; Lhamas A; Coelho T; Ribeiro A; Esteves S; Pereira R; Almeida R; Amil M; Cabrita A; Teixeira M
    Transplant Proc; 2006; 38(6):1929-32. PubMed ID: 16908326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection in simultaneous kidney and pancreas transplant recipients.
    Peddi VR; Kamath S; Schroeder TJ; Munda R; First MR
    Transplant Proc; 1998 Mar; 30(2):285-7. PubMed ID: 9532041
    [No Abstract]   [Full Text] [Related]  

  • 47. Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report.
    Manitpisitkul W; Wilson N; Cooper M; Gurk-Turner C; Hurley H; Rasetto F; KuKuruga D; Barth RN; Philosophe B
    Clin Transpl; 2009; ():461-3. PubMed ID: 20524315
    [No Abstract]   [Full Text] [Related]  

  • 48. The incidence of interstitial and vascular kidney rejection after pancreas-kidney transplantation.
    Boonstra JG; Bruijn JA; Hermans J; Lemkes HH; Ringers J; van der Pijl H; van der Woude FJ
    J Am Soc Nephrol; 1995 May; 5(11):1918-25. PubMed ID: 7620088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion to sirolimus in kidney-pancreas and pancreas transplantation.
    Matias P; Araujo MR; Romão JE; Abensur H; Noronha IL
    Transplant Proc; 2008 Dec; 40(10):3601-5. PubMed ID: 19100448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients.
    Kliem V; Schaumann D; Ehlerding G; Eberhard OK; Lufft V; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
    Transplant Proc; 1997 Nov; 29(7):2955-7. PubMed ID: 9365627
    [No Abstract]   [Full Text] [Related]  

  • 51. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation.
    Uslu A; Tokat Y; Ok E; Unsal A; Ilkgul O; Kaplan H
    Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation.
    Teraoka S; Babazono T; Koike T; Abe M; Kimikawa M; Shinkai M; Haruguchi H; Hirotani S; Kitajima K; Akamatsu M
    Transplant Proc; 1995 Feb; 27(1):1335-9. PubMed ID: 7533381
    [No Abstract]   [Full Text] [Related]  

  • 53. Pancreas-kidney transplantation in Japan: impact of cyclosporine on the development of immunosuppressive therapy.
    Sugitani A; Ishibashi M; Ito T; Nakajima K; Matsuno N; Kanazawa Y; Motoyama K; Yamamoto H; Inoue S; Ota M; Yoshida JI; Tanaka M
    Transplant Proc; 2004 Mar; 36(2 Suppl):356S-361S. PubMed ID: 15041368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
    Inui M; Tanabe K; Ishikawa N; Tokumoto T; Harano M; Otsubo S; Suzuki K; Goya N; Yagisawa T; Nakazawa H; Fuchinoue S; Toma H
    Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics.
    Eghtesad B; Malhotra D; Hecker WP; Haq M; Gibel LJ; Wheeler D; Smith AY; Harford AM
    Transplant Proc; 1998 Jun; 30(4):1232-3. PubMed ID: 9636500
    [No Abstract]   [Full Text] [Related]  

  • 56. Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus.
    Chakkera HA; Bodner JK; Heilman RL; Mulligan DC; Moss AA; Mekeel KL; Mazur MJ; Hamawi K; Ray RM; Beck GL; Reddy KS
    Transplant Proc; 2010 Sep; 42(7):2650-2. PubMed ID: 20832562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy.
    Kehinde EO; Feehally J; Scriven SD; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1449-50. PubMed ID: 8658735
    [No Abstract]   [Full Text] [Related]  

  • 58. OKT3 induction in 100 consecutive pancreas transplants.
    Stratta RJ; Taylor RJ; Lowell JA; Bynon JS; Cattral MS; Frisbie K; Miller S; Brennan DC
    Transplant Proc; 1994 Apr; 26(2):546-7. PubMed ID: 8171546
    [No Abstract]   [Full Text] [Related]  

  • 59. Four-year results of pancreas transplantation in Taiwan.
    Chao SH
    Transplant Proc; 2000 Nov; 32(7):2467-8. PubMed ID: 11120247
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation.
    Zanker B; Sohr B; Eder M; Frohmann E; Land W
    Transplant Proc; 1999; 31(1-2):1167. PubMed ID: 10083521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.